Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and Bayesian network meta-analysis - Quiz - MDSpire

Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and Bayesian network meta-analysis

  • By

  • Yan Wang

  • Xiaoyan Wang

  • Guihong Yu

  • Libao Zhang

  • Changhui Xue

  • Wanchen Gong

  • Jiashou Luo

  • Chengwu Lu

  • Linfeng Wang

  • July 9, 2026

  • 0 min

Share

Original Source(s)

Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and Bayesian network meta-analysis

  • by Yan Wang, Xiaoyan Wang, Guihong Yu, Libao Zhang, Changhui Xue, Wanchen Gong, Jiashou Luo, Chengwu Lu, Linfeng Wang

  • July 9, 2026

Related Content

Longitudinal changes in anatomic biomarkers on optical coherence tomography angiography in diabetic retinopathy

Combined impact of glucose variability and mineral disorders on mortality and severe cardiorenal events in critically ill CKD patients: a multicenter cohort study

Case Report: Continuous block-and-replace strategy with osilodrostat in a patient with cyclic Cushing’s syndrome